Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SNT-5382 by Syntara for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
SNT-5382 is under clinical development by Syntara and currently in Phase I for Chronic Kidney Disease (Chronic Renal Failure). According...